DiscoverThe Lupus ForumDiscussing Lupus: Voclosporin immunosuppressive therapy and new ACR guidelines for lupus nephritis
Discussing Lupus: Voclosporin immunosuppressive therapy and new ACR guidelines for lupus nephritis

Discussing Lupus: Voclosporin immunosuppressive therapy and new ACR guidelines for lupus nephritis

Update: 2024-12-23
Share

Description

Steering Committee member Professor Maria Dall’Era, Professor of Medicine and Chief of the Division of Rheumatology at the of University of California, San Francisco, USA, is joined by fellow member Professor Brad Rovin, who is Lee A. Hebert Professor of Nephrology and Medical Director at Ohio State University Clinical Research Management Institute, Columbus, Ohio, on the latest Lupus Forum podcast.

Together, they discuss the efficacy and safety of a voclosporin-based triple immunosuppressive regimen and summarise the latest ACR guidance to screen, treat, and manage lupus nephritis. If you are interested in the paper discussed, head on over to the Lupus Forum today! Download our latest slide decks and stay up to date with our monthly podcasts, all through this free independent resource: https://lupus-forum.com/
Comments 
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Discussing Lupus: Voclosporin immunosuppressive therapy and new ACR guidelines for lupus nephritis

Discussing Lupus: Voclosporin immunosuppressive therapy and new ACR guidelines for lupus nephritis

The Lupus Forum